MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- Indian - food & tobacco
- GSK CONSUMER - KRBL
GSK CONSUMER vs KRBL - Comparison Results
GSK CONSUMER Change
GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More
KRBL 
The history of KRBL can be traced all the way back to 1889 though the company in its current form came into existence much later. The company has been a significant player and an exporter of basmati rice since 1993. With a milling capacity of 195 MT ... More
Current Valuations
| GSK CONSUMER | KRBL | GSK CONSUMER/ KRBL |
|||
|---|---|---|---|---|---|
| P/E (TTM) | x | 39.1 | 11.6 | 337.4% | View Chart |
| P/BV | x | 11.0 | 2.4 | 465.3% | View Chart |
| Dividend Yield | % | 1.0 | 0.9 | 107.4% |
Financials
 GSK CONSUMER  KRBL |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| GSK CONSUMER Mar-19 |
KRBL Mar-19 |
GSK CONSUMER/ KRBL |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 7,819 | 564 | 1,386.4% | |
| Low | Rs | 5,832 | 277 | 2,105.3% | |
| Sales per share (Unadj.) | Rs | 1,136.9 | 175.0 | 649.5% | |
| Earnings per share (Unadj.) | Rs | 233.7 | 21.4 | 1,093.4% | |
| Cash flow per share (Unadj.) | Rs | 248.1 | 24.1 | 1,029.0% | |
| Dividends per share (Unadj.) | Rs | 105.00 | 2.50 | 4,200.0% | |
| Dividend yield (eoy) | % | 1.5 | 0.6 | 258.7% | |
| Book value per share (Unadj.) | Rs | 973.5 | 115.8 | 840.4% | |
| Shares outstanding (eoy) | m | 42.06 | 235.39 | 17.9% | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 6.0 | 2.4 | 249.9% | |
| Avg P/E ratio | x | 29.2 | 19.7 | 148.4% | |
| P/CF ratio (eoy) | x | 27.5 | 17.4 | 157.8% | |
| Price / Book Value ratio | x | 7.0 | 3.6 | 193.1% | |
| Dividend payout | % | 44.9 | 11.7 | 384.1% | |
| Avg Mkt Cap | Rs m | 287,083 | 98,981 | 290.0% | |
| No. of employees | `000 | 3.8 | NA | - | |
| Total wages/salary | Rs m | 6,446 | 770 | 837.0% | |
| Avg. sales/employee | Rs Th | 12,440.2 | NM | - | |
| Avg. wages/employee | Rs Th | 1,677.0 | NM | - | |
| Avg. net profit/employee | Rs Th | 2,556.7 | NM | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 47,820 | 41,205 | 116.1% | |
| Other income | Rs m | 4,326 | 152 | 2,855.4% | |
| Total revenues | Rs m | 52,146 | 41,356 | 126.1% | |
| Gross profit | Rs m | 11,410 | 8,499 | 134.3% | |
| Depreciation | Rs m | 606 | 645 | 93.9% | |
| Interest | Rs m | 8 | 676 | 1.2% | |
| Profit before tax | Rs m | 15,123 | 7,330 | 206.3% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 5,295 | 2,300 | 230.2% | |
| Profit after tax | Rs m | 9,828 | 5,030 | 195.4% | |
| Gross profit margin | % | 23.9 | 20.6 | 115.7% | |
| Effective tax rate | % | 35.0 | 31.4 | 111.6% | |
| Net profit margin | % | 20.6 | 12.2 | 168.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 52,674 | 35,741 | 147.4% | |
| Current liabilities | Rs m | 18,140 | 17,229 | 105.3% | |
| Net working cap to sales | % | 72.2 | 44.9 | 160.8% | |
| Current ratio | x | 2.9 | 2.1 | 140.0% | |
| Inventory Days | Days | 36 | 277 | 12.8% | |
| Debtors Days | Days | 29 | 35 | 83.6% | |
| Net fixed assets | Rs m | 4,798 | 9,418 | 50.9% | |
| Share capital | Rs m | 421 | 235 | 178.7% | |
| "Free" reserves | Rs m | 40,527 | 27,032 | 149.9% | |
| Net worth | Rs m | 40,947 | 27,267 | 150.2% | |
| Long term debt | Rs m | 0 | 332 | 0.0% | |
| Total assets | Rs m | 60,681 | 46,361 | 130.9% | |
| Interest coverage | x | 1,939.8 | 11.8 | 16,375.1% | |
| Debt to equity ratio | x | 0 | 0 | 0.0% | |
| Sales to assets ratio | x | 0.8 | 0.9 | 88.7% | |
| Return on assets | % | 16.2 | 12.3 | 131.7% | |
| Return on equity | % | 24.0 | 18.4 | 130.1% | |
| Return on capital | % | 37.0 | 29.0 | 127.4% | |
| Exports to sales | % | 0 | 34.2 | 0.0% | |
| Imports to sales | % | 0 | 0 | - | |
| Exports (fob) | Rs m | NA | 14,093 | 0.0% | |
| Imports (cif) | Rs m | NA | NA | - | |
| Fx inflow | Rs m | 3,171 | 29,027 | 10.9% | |
| Fx outflow | Rs m | 1,770 | 841 | 210.4% | |
| Net fx | Rs m | 1,401 | 28,186 | 5.0% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 6,711 | -1,144 | -586.8% | |
| From Investments | Rs m | -3,351 | 202 | -1,658.7% | |
| From Financial Activity | Rs m | -3,768 | 595 | -633.4% | |
| Net Cashflow | Rs m | -408 | -347 | 117.6% | |
Share Holding
| Indian Promoters | % | 0.0 | 58.7 | - | |
| Foreign collaborators | % | 72.5 | 0.0 | - | |
| Indian inst/Mut Fund | % | 0.8 | 0.0 | 4,000.0% | |
| FIIs | % | 12.0 | 5.3 | 226.4% | |
| ADR/GDR | % | 0.0 | 0.0 | - | |
| Free float | % | 14.8 | 36.0 | 41.1% | |
| Shareholders | 26,457 | 19,338 | 136.8% | ||
| Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare GSK CONSUMER With: KWALITY GUJ.AMB.EXP. VST INDUSTRIES UNITED BREWERIES GOODRICKE
Compare GSK CONSUMER With: COCA COLA (US) TIGER BRANDS (S. Africa) NESTLE (Switz.) AVI LTD. (S. Africa)
Today's Market
Sensex Ends 408 Points Higher; Banking and Metal Stocks Witness Buying(Closing)
Indian share markets witnessed buying interest after a 1-day hiatus and ended on a strong note today.
Related Views on News
P&G HYGIENE Share Price Up by 6%; BSE FMCG Index Up 0.1% (Market Updates)
Jul 9, 2020 | Updated on Jul 9, 2020P&G HYGIENE share price is trading up by 6% and its current market price is Rs 11,318. The BSE FMCG is up by 0.1%. The top gainers in the BSE FMCG Index are P&G HYGIENE (up 6.1%) and GSK CONSUMER (up 5.1%). The top losers are GODFREY PHILLIPS (down 0.2%) and DABUR (down 0.3%).
KRBL Announces Quarterly Results (4QFY20); Net Profit Up 8.0% (Quarterly Result Update)
Jun 11, 2020 | Updated on Jun 11, 2020For the quarter ended March 2020, KRBL has posted a net profit of Rs 1 bn (up 8.0% YoY). Sales on the other hand came in at Rs 11 bn (down 11.2% YoY). Read on for a complete analysis of KRBL's quarterly results.
GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)
Feb 7, 2020 | Updated on Feb 7, 2020For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
KRBL Announces Quarterly Results (3QFY20); Net Profit Up 48.3% (Quarterly Result Update)
Jan 30, 2020 | Updated on Jan 30, 2020For the quarter ended December 2019, KRBL has posted a net profit of Rs 2 bn (up 48.3% YoY). Sales on the other hand came in at Rs 13 bn (up 42.0% YoY). Read on for a complete analysis of KRBL's quarterly results.
GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)
Nov 14, 2019 | Updated on Nov 14, 2019For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
More Views on NewsMost Popular
How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)
Jul 2, 2020In the first of two videos, I'll show you how to identify the best stocks for intraday trading.
Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)
Jul 2, 2020Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...
A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)
Jun 30, 2020If you are a trader, you must watch out for this dangerous addiction.
Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)
Jul 3, 2020This is why I believe smallcaps are the place to be in the near future.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2020
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
GSK CONSUMER SHARE PRICE
Apr 15, 2020 (Close)
TRACK GSK CONSUMER
- Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON GSK CONSUMER
GSK CONSUMER 5-YR ANALYSIS
COMPARE GSK CONSUMER WITH
FEATURED VIDEOS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.